ACRS icon

Aclaris Therapeutics
ACRS

Overview Fund Activity

71 hedge funds and large institutions have $33.4M invested in Aclaris Therapeutics in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 24 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
71
Holders Change
-8
Holders Change %
-10.13%
% of All Funds
1.57%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
12
Increased
17
Reduced
24
Closed
16
Calls
$7K
Puts
$1K
Net Calls
+$6K
Net Calls Change
-$105K

Top Buyers

1
SB
1
Samsara BioCapital
California
$2.71M
2
VC
2
Vivo Capital
California
$1.71M
3
PHP
3
Parkman Healthcare Partners
Connecticut
$1.6M
4
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$2.08M
5
ECM
5
Endurant Capital Management
California
$2.72M

Top Sellers

1
Morgan Stanley
1
Morgan Stanley
New York
$3K
2
Man Group
2
Man Group
United Kingdom
$97K
3
Millennium Management
3
Millennium Management
New York
$0
4
Jacobs Levy Equity Management
4
Jacobs Levy Equity Management
New Jersey
$0
5
BCM
5
Bridgeway Capital Management
Texas
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
PP
76
Paloma Partners
Connecticut
– -$28K -14,650 Closed
Group One Trading
77
Group One Trading
Illinois
– -$22K -11,451 Closed
OSAM
78
O'Shaughnessy Asset Management
Connecticut
– -$11K -5,826 Closed
Bank of Montreal
79
Bank of Montreal
Ontario, Canada
– -$10K -5,491 Closed
SFS
80
Sowell Financial Services
Arkansas
– -$1K -400 Closed
1 2 3
4